Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

J. Janssen · SciRah

Researcher profile · Semantic Scholar

J. Janssen

Share profile

J. Janssen — researcher profile on SciRah

h-index: 10
Works: 29
Citations: 290

Most-cited papers

Development and validation of a liquid chromatography-tandem mass spectrometry assay for nine oral anticancer drugs in human plasma.
J. Janssen, N. de Vries, N. Venekamp, H. Rosing +2 more
2019Journal of Pharmaceutical and Biomedical Analysis47 citations Open access
Semantic Scholar
Exposure–Response Analyses of Anaplastic Lymphoma Kinase Inhibitors Crizotinib and Alectinib in Non‐Small Cell Lung Cancer Patients
S. Groenland, D. R. Geel, J. Janssen, N. de Vries +6 more
2020Clinical pharmacology and therapy45 citations Open access
Semantic Scholar
Evaluation of extrapolation methods to predict trough concentrations to guide therapeutic drug monitoring of oral anticancer drugs.
J. Janssen, T. P. C. Dorlo, J. H. Beijnen, A. Huitema
2020Therapeutic Drug Monitoring24 citations
Semantic Scholar
Population Pharmacokinetics of Docetaxel, Paclitaxel, Doxorubicin and Epirubicin in Pregnant Women with Cancer: A Study from the International Network of Cancer, Infertility and Pregnancy (INCIP)
J. Janssen, K. Van Calsteren, T. P. C. Dorlo, M. Halaška +11 more
2021Clinical Pharmacokinetics23 citations Open access
Semantic Scholar
Therapeutic Drug Monitoring of Gentamicin Peak Concentrations in Critically Ill Patients
C. Hodiamont, J. Janssen, M. D. de Jong, R. Mathôt +2 more
2017Therapeutic Drug Monitoring22 citations Open access
Semantic Scholar
Pharmacokinetic Targets for Therapeutic Drug Monitoring of Small Molecule Kinase Inhibitors in Pediatric Oncology.
J. Janssen, T. P. C. Dorlo, N. Steeghs, J. H. Beijnen +5 more
2020Clinical pharmacology and therapy19 citations Open access
Semantic Scholar
Longitudinal nonlinear mixed effects modeling of EGFR mutations in ctDNA as predictor of disease progression in treatment of EGFR‐mutant non‐small cell lung cancer
J. Janssen, R. Verheijen, T. V. van Duijl, Lishi Lin +6 more
2022Clinical and Translational Science17 citations Open access
Semantic Scholar
Therapeutic drug monitoring of small molecule kinase inhibitors in oncology in a real‐world cohort study: does age matter?
Marie-Rose B. S. Crombag, Jacobine G. C. van Doremalen, J. Janssen, H. Rosing +4 more
2018British Journal of Clinical Pharmacology16 citations Open access
Semantic Scholar
A Population Pharmacokinetic Model of Oral Docetaxel Coadministered With Ritonavir to Support Early Clinical Development
Hui-Xin Yu, J. Janssen, E. Sawicki, J. G. Coen Hasselt +5 more
2019Journal of clinical pharmacology12 citations Open access
Semantic Scholar
ModraDoc006, an oral docetaxel formulation in combination with ritonavir (ModraDoc006/r), in metastatic castration‐resistant prostate cancer patients: A phase Ib study
M. Vermunt, D. Robbrecht, L. Devriese, J. Janssen +8 more
2021Cancer Reports11 citations Open access
Semantic Scholar
Exposure–response analyses of BRAF- and MEK-inhibitors dabrafenib plus trametinib in melanoma patients
S. Groenland, J. Janssen, C. Nijenhuis, N. de Vries +8 more
2023Cancer Chemotherapy and Pharmacology8 citations
Semantic Scholar
Population Pharmacokinetics of Intracellular 5-Fluorouridine 5′-Triphosphate and its Relationship with Hand-and-Foot Syndrome in Patients Treated with Capecitabine
J. Janssen, B. Jacobs, J. Roosendaal, Ellen J B Derissen +4 more
2021AAPS Journal7 citations Open access
Semantic Scholar
Clinical trial simulations in paediatric oncology: A feasibility study from the Innovative Therapies for Children with Cancer Consortium.
J. Janssen, C. Zwaan, J. Schellens, J. Beijnen +1 more
2017European Journal of Cancer6 citations Open access
Semantic Scholar
Effect of Food on the Pharmacokinetics of the Oral Docetaxel Tablet Formulation ModraDoc006 Combined with Ritonavir (ModraDoc006/r) in Patients with Advanced Solid Tumours
M. Vermunt, V. D. de Weger, J. Janssen, M. I. Lopez-Yurda +6 more
2021Drugs in R&D5 citations Open access
Semantic Scholar
567P Exposure-response analyses of dabrafenib and trametinib in melanoma patients
S. Groenland, J. Janssen, C. Nijenhuis, N. de Vries +8 more
20205 citations Open access
Semantic Scholar
Monitoring of EGFR mutations in circulating tumor DNA of non-small cell lung cancer patients treated with EGFR inhibitors
R. Verheijen, T. V. van Duijl, M. van den Heuvel, D. Vessies +7 more
2021Cancer Chemotherapy and Pharmacology4 citations
Semantic Scholar
ModraDoc006, an oral docetaxel formulation in combination with ritonavir (ModraDoc006/r), in metastasized castration-resistant prostate cancer (mCRPC): A multicenter phase I study.
M. Vermunt, D. Robbrecht, L. Devriese, J. Janssen +5 more
20204 citations
Semantic Scholar
Azacitidine (Vidaza^®) in Pediatric Patients with Relapsed Advanced MDS and JMML: Results of a Phase I/II Study by the ITCC Consortium and the EWOG-MDS Group (Study ITCC-015)
A. Rubio-San-Simón, N. van Eijkelenburg, R. Hoogendijk, H. Hasle +10 more
2023Pediatric Drugs3 citations Open access
Semantic Scholar
Exposure-response analyses of ALK-inhibitors crizotinib and alectinib in NSCLC patients
S. Groenland, D. R. Geel, J. Janssen, J. Beijnen +4 more
2019Annals of Oncology3 citations Open access
Semantic Scholar
A Semi-Mechanistic Population Pharmacokinetic/Pharmacodynamic Model of Bortezomib in Pediatric Patients with Relapsed/Refractory Acute Lymphoblastic Leukemia
J. Janssen, T. P. C. Dorlo, D. Niewerth, A. J. Wilhelm +11 more
2019Clinical Pharmacokinetics3 citations Open access
Semantic Scholar
Semi-physiological Enriched Population Pharmacokinetic Modelling to Predict the Effects of Pregnancy on the Pharmacokinetics of Cytotoxic Drugs
J. Janssen, D. Damoiseaux, J. V. van Hasselt, F. Amant +4 more
2023Clinical Pharmacokinetics2 citations Open access
Semantic Scholar
Quantification of the pharmacokinetic-toxicodynamic relationship of oral docetaxel co-administered with ritonavir
Hui-Xin Yu, J. Janssen, V. D. de Weger, B. Nuijen +6 more
2020Investigational new drugs1 citations
Semantic Scholar
Addition of an oral docetaxel treatment (ModraDoc006/r) to androgen deprivation therapy (ADT) and intensity-modulated radiation therapy (IMRT) in patients with high risk N+M0 prostate cancer
M. Vermunt, J. Janssen, G. L. Vrijenhoek, H. G. van der Poel +3 more
2019Annals of Oncology1 citations Open access
Semantic Scholar
Tyrosine kinase inhibitor levels matter in treating chronic GVHD
L. E. van der Wagen, J. Janssen, R. Raijmakers, E. Petersen +8 more
2019Bone Marrow Transplantation1 citations Open access
Semantic Scholar
De kwaliteit van doseringsadviezen bij therapeutic drug monitoring van aminoglycosiden op de intensive care
G. van den Hurk, J. Janssen, N. Juffermans, R. van Hest
20151 citations
Semantic Scholar
Application of modelling and simulation to optimize anticancer treatment of special patient populations
J. Janssen
20200 citations
Semantic Scholar
Efficacy, Tolerance, and Plasma Levels of Abiraterone and Its Main Metabolites in a Patient With Metastatic Castration-resistant Prostate Cancer With a Hepatic Transplant.
M. van Nuland, J. Janssen, B. van Hoek, H. Rosing +2 more
2019Clinical Genitourinary Cancer0 citations Open access
Semantic Scholar
AZACITIDINE (VIDAZA®) IN PEDIATRIC PATIENTS WITH RELAPSED ADVANCED MDS: RESULTS OF A PHASE I/II STUDY BY THE ITCC CONSORTIUM AND THE EWOG-MDS GROUP: STUDY ITCC-015
N. van Eijkelenburg, M. M. van den Heuvel-Eibrink, H. Hasle, C. Niemeyer +7 more
2019HemaSphere0 citations Open access
Semantic Scholar
in paediatric oncology: A feasibility study from the Innovative Therapies for Children with Cancer Consortium
J. Janssen, C. Zwaan, J. Schellens, J. H. Beijnen +1 more
0 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

J. Beijnen×17
Invite
J. Beijnen — researcher profile on SciRah
A. Huitema×11
Invite
A. Huitema — researcher profile on SciRah
A. Huitema×10
Invite
A. Huitema — researcher profile on SciRah
H. Rosing×7
Invite
H. Rosing — researcher profile on SciRah

×7

Invite

T. P. C. Dorlo — researcher profile on SciRah

Invite

N. Steeghs — researcher profile on SciRah

Invite

C. Zwaan — researcher profile on SciRah

Invite

N. de Vries — researcher profile on SciRah

S. Groenland×4

Invite

S. Groenland — researcher profile on SciRah

J. H. Beijnen×4

Invite

J. H. Beijnen — researcher profile on SciRah

J. Schellens×4

Invite

J. Schellens — researcher profile on SciRah

Invite

M. Vermunt — researcher profile on SciRah